2021-01-11,"Celyad Oncology Appoints Marina Udier, Ph.D., to Board of Directors"
2021-01-07,Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital
2021-01-05,Celyad Oncology Announces January 2021 Conference Schedule
2020-12-15,Celyad Oncology Successfully Doses First Patient in Expansion Cohort of the CYAD-101 Phase 1 alloSHRINK Trial for mCRC
2020-12-07,Celyad Oncology Provides Updates on Allogeneic and Autologous CAR T Programs at 62nd ASH Annual Meeting and Exposition
2020-12-04,Celyad Oncology Announces Dosing of First Patient in Phase 1 IMMUNICY-1 Trial of CYAD-211 for Multiple Myeloma
2020-12-01,Celyad Oncology to Participate in a Fireside Chat at the JMP Securities Hematology Summit
2020-11-29,"The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions"
2020-11-10,Celyad Oncology Announces Third Quarter 2020 Financial Results and Recent Business Highlights
2020-11-04,Celyad Oncology to Present Updates from Allogeneic and Autologous CAR T Programs at 62nd ASH Annual Meeting and Exposition
2020-11-02,Celyad Oncology Announces November 2020 Investor Conference Schedule
2020-09-29,Celyad-Merck Team Up to Evaluate CYAD-101 in Colorectal Cancer
2020-09-29,"The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut"
2020-09-29,Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDAÂ® (pembrolizumab) in Patients with Microsatellite Stable mCRC
2020-09-23,Celyad Oncology to Participate in a Fireside Chat at the 7th Annual Jefferies Cell Therapy Summit
2020-09-22,Celyad Oncology to Host Virtual Research & Development Webinar on September 29
2020-09-14,Celyad Oncology Establishes At-the-Market Facility
2020-08-26,Celyad Oncology Announces September 2020 Conference Schedule
2020-08-26,Celyad Oncology Announces September 2020 Conference Schedule
2020-08-06,Celyad Oncology Reports Half Year 2020 Financial Results and Second Quarter Business Highlights
2020-08-03,Celyad Oncology to Announce First Half 2020 Financial Results and Host Conference Call
2020-08-03,Celyad Oncology to Announce First Half 2020 Financial Results and Host Conference Call
2020-07-15,Ceylad Gets FDA Nod to Begin Phase I Study on CAR T Candidate
2020-07-14,"Celyad Oncology Announces FDA Clearance of IND Application for CYAD-211, First shRNA-based, Non-Gene Edited Allogeneic CAR T Therapy"
2020-07-14,"Celyad Oncology Announces FDA Clearance of IND Application for CYAD-211, First shRNA-based, Non-Gene Edited Allogeneic CAR T Therapy"
2020-06-10,Celyad Rebrands as Celyad Oncology
2020-06-01,Celyad Provides Update on Allogeneic CAR-T Franchise including CYAD-101 and shRNA Platform at the 2020 ASCO Virtual Scientific Program
2020-05-27,5 Health Care Stocks to Bet on as Coronavirus Woes Linger
2020-05-26,Celyad Announces June 2020 Conference Schedule
2020-05-25,All You Need to Know About Celyad SA (CYAD) Rating Upgrade to Strong Buy
2020-05-24,3 Strong Buy Healthcare Stocks That Could Double in the Next Year
2020-05-07,Celyad Announces First Quarter 2020 Financial Results and Recent Business Highlights
2020-05-06,Celyad Appoints Seasoned Industry Executives to Board of Directors
2020-04-30,Celyad to Present Update from CYAD-101 for Advanced Colorectal Cancer and Next-Generation shRNA Platform at 2020 ASCO Virtual Scientific Program
2020-04-22,Celyad to Host Remote 2020 Ordinary General Meeting
2020-04-20,Top Ranked Momentum Stocks to Buy for April 20th
2020-03-31,What Makes Celyad SA (CYAD) a New Buy Stock
2020-03-26,Imagine Owning Celyad (EBR:CYAD) And Trying To Stomach The 84% Share Price Drop
2020-03-25,Celyad SA to Host Earnings Call
2020-03-24,Celyad Reports Full Year 2019 Financial Results and Provides Business Update
2020-03-12,Celyad to Announce Full Year 2019 Financial Results and Host Conference Call
2020-03-02,Celyad Appoints Stephen Rubino as Chief Business Officer
2020-02-17,Celyad Announces February and March 2020 Conference Schedule
2020-01-13,Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS
2019-12-10,Celyad Presents Update on r/r AML and MDS Program at 61st ASH Annual Meeting
2019-12-09,Celyad Presents Update on r/r AML and MDS Program at 61st ASH Annual Meeting
2019-12-07,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling"
2019-12-06,Celyad Receives Additional 2.5 Million in Non-Dilutive Funding
2019-12-06,Celyad Receives Additional 2.5 Million in Non-Dilutive Funding
2019-12-03,Celyad Announces Board of Directors Evolution with New Appointment
2019-11-29,Celyad Announces Board of Directors Evolution with New Appointment
2019-11-22,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate"
2019-11-22,Celyad Receives 8.5 Million in Grants and Non-Dilutive Funding by the Walloon Region
2019-11-19,Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights
2019-11-19,Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights
2019-11-13,Celyad SA (CYAD) Moves to Buy: Rationale Behind the Upgrade
2019-11-11,"Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting"
2019-11-06,Celyad to Present Update to r/r AML and MDS Program at 2019 ASH Annual Meeting
2019-11-05,Celyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual Meeting
2019-11-05,Celyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual Meeting
2019-11-03,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight"
2019-10-22,Does Celyad SA (EBR:CYAD) Have A Volatile Share Price?
2019-10-02,Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting
2019-10-02,Celyad Announces October and November 2019 Investor Conference Schedule
2019-09-16,Celyad Announces Closing of $20 Million Global Offering
2019-09-12,Celyad Announces Pricing of $20.0 Million Global Offering
2019-09-12,Celyad Announces Pricing of $20.0 Million Global Offering
2019-09-11,"The Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets Underway"
2019-09-10,Celyad Announces Launch of Proposed Global Offering
2019-09-04,Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process
2019-09-04,Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process
2019-08-29,Celyad to Participate in Upcoming September 2019 Conferences
2019-08-22,Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
2019-08-22,Some Celyad (EBR:CYAD) Shareholders Have Taken A Painful 71% Share Price Drop
2019-08-16,Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call
2019-07-15,Celyad Sees Hammer Chart Pattern: Time to Buy?
2019-07-05,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight"
2019-07-05,Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
2019-07-02,Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
2019-07-02,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug"
2019-07-01,Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program
2019-06-21,Celyad SA Sees Hammer Chart Pattern: Time to Buy?
2019-06-17,Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association
2019-06-03,Celyad Sees Hammer Chart Pattern: Time to Buy?
2019-05-29,Celyad to Participate in Upcoming June 2019 Conferences
2019-05-16,Celyad to Present Data at 24th Congress of the European Hematology Association
2019-05-09,Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights
2019-05-02,Celyad Announces May 2019 Investor Conference Schedule
2019-04-17,Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refractory mCRC at ESMO 21st World GI Congress
2019-04-01,Celyad Announces April 2019 Investor Conference Schedule
2019-03-28,Celyad Reports Business Update and Full Year 2018 Financial and Operating Results
2019-03-28,Celyad Appoints Filippo Petti as Chief Executive Officer
2019-03-18,Celyads 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates
2019-03-11,"Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City"
2019-03-08,Celyad Appoints Anne Moore as Vice President Corporate Strategy
2019-02-21,Celyad Announces February and March 2019 Investor Conference Schedule
2019-01-07,Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS
2018-12-04,Celyad Presents Update on CYAD-01 Hematological Malignancies Clinical Program at 60th ASH Annual Meeting
2018-11-30,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings"
2018-11-30,"Celyad Doses First mCRC Patient in the Phase 1 alloSHRINK Trial Evaluating Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101"
